Novartis AG

Open: 97.79 Close: 98.01 Change: 0.22

Our AI found unexpected things about Novartis AG.

Are looking for the most relevant information about Novartis AG? Investor spend a lot of time searching for information to make investment decisions in Novartis AG. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, development, Chinook, Therapeutics, deal, drug, and the most common words in the summary are: novartis, stock, market, news, price, company, day, . One of the sentences in the summary was: Novartis AG shareholders have earned a 9.9% CAGR over the last …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis AG shareholders have earned a 9.9% CAGR over the last five years. Shareholders have enjoyed a 17% share price rise in the last half decade, well in excess of the market return.

Today's News

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. Chinook Therapeutics stock Surges After Novartes Agrees to $3.5 billion deal with Swiss drug major. Novartis AG (NYSE:NVS) Given Average Recommendation of “Hold” of ‘Hold’ in quarterly earnings report. Novartis AG shareholders have earned a 9.9% CAGR over the last five years. Shareholders have enjoyed a 17% share price rise in the last half decade, well in excess of the market return of around 13% (not including dividends) Novartis announced Monday it plans to buy Seattle-based Chinook Therapeutics for $3.5 billion. The deal will boost its late-stage drug development line-up.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

How much time have you spent trying to decide whether investing in Novartis AG? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, development, Chinook, Therapeutics, deal, drug, and the most common words in the summary are: novartis, stock, market, news, price, company, day, . One of the sentences in the summary was: Novartis AG shareholders have earned a 9.9% CAGR over the last five years. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #stock #market #news #price #company #day.